Telma Act 40/5/12.5Mg 15 Tablets

Babies: Not applicable. Lactating mothers: It is probably safe to use during breastfeeding. Limited human data suggests that the drug does not represent any significant risk to the baby. Pregnancy: It is unsafe to use during pregnancy.
Driving: AMLODIPINE, chlorthalidone, telmisartan tablet may decrease alertness, affects vision and may cause dizziness and sleep. Do not drive if these symptoms occur. Alcohol: Avoid consumption of alcohol while taking this tablet. Kidney: AMLODIPINE, chlorthalidone, telmisartan tablet should be used in caution with patients suffering from kidney disease.
Dosage adjustment is required, and regular monitoring of kidney function may be required. Seek a doctor’s advice before using this medication. Liver: AMLODIPINE, chlorthalidone, telmisartan tablet should be used to caution patients suffering from liver disease.
Dosage adjustment is required, and regular monitoring of liver function may be required. Seek a doctor’s advice before using this medication.
.

Ankle swelling Headache Dizziness Tiredness Palpitations Sleepiness Increased blood uric acid Glucose intolerance Taste change Flushing (sense of warmth in the face, ears, neck and trunk) Upset stomach Altered blood lipid level.